Mastering Excision and Reconstruction of Hand Malignancies: SCC & Melanoma

Excision and Coverage of Squamous Cell Carcinoma and Melanoma of the Hand: An Intraoperative Masterclass

Alright, team, gather around. Today, we're tackling a critical area: the excision and subsequent coverage of squamous cell carcinoma (SCC) and melanoma of the hand and upper extremity. These are not merely skin lesions; they represent malignant transformations demanding our utmost precision and oncologic rigor. Our primary goal is always tumor clearance, followed by meticulous reconstruction to preserve both form and function. This requires a deep understanding of the disease, comprehensive planning, and flawless execution.

Understanding the Enemy: Pathology and Natural History

Let's begin by reviewing the fundamental pathology. Squamous cell carcinoma and melanoma are distinct entities, yet both pose significant threats to our patients.

Squamous Cell Carcinoma (SCC)

SCCs originate from epidermal keratinocyte cell layers, though they can also arise in the nail matrix complex. We often see these in patients with a history of chronic sun exposure, severe burns, chronic ulcers, increasing age, or immune compromise (e.g., organ transplant recipients, AIDS patients). Clinically, a typical SCC lesion presents as a rapidly growing, firm, scaly papule or nodule that often develops a central ulcer and an indurated, raised border with surrounding inflammation. Crucially, it lacks the pearly, telangiectatic perimeter characteristic of basal cell carcinomas.

• Grading: SCC is graded from 1 to 4 based on the proportion of differentiating cells, the degree of atypicality of tumor cells, and the depth of tumor penetration. This grading directly influences our surgical approach and prognosis.

Melanoma

Melanoma cells derive from dendritic melanocytes, which originate from neural crest cells. These cells migrate to both cutaneous and noncutaneous locations, with the nail apparatus being a significant site in the upper extremity. While melanomas are typically pigmented and reflect irregular color, surface, and perimeter, it's vital to remember that amelanotic melanomas exist and can be deceptively benign in appearance. Risk factors include personal or family history of melanoma, changing moles, sun sensitivity, excessive sun exposure, immune compromise, and exposure to various carcinogens.

• Subtypes: The main clinicopathologic subtypes include superficial spreading (most common, ~70%), nodular (15-30%, often more aggressive), lentigo maligna, and acral lentiginous (common on palms, soles, and subungual regions).
• Microstaging: We rely heavily on Breslow thickness (vertical thickness in millimeters) as it is more reproducible and accurately predicts prognosis for lesions thicker than 1.5 mm. Clark level (anatomic level of local invasion, I to V) provides additional detail but can be less concordant.
• Natural History: Both SCC and melanoma can extend locally, involve regional lymph node basins, and metastasize to distant sites. A thorough understanding of their potential for spread is paramount for accurate staging and management.

Comprehensive Surgical Anatomy of the Hand and Upper Extremity

Before we make any incision, a detailed understanding of the regional anatomy is non-negotiable. The hand is a complex structure, and preserving its intricate neurovascular and tendinous elements is critical for functional outcomes.

Skin and Subcutaneous Tissues

The skin of the hand varies significantly in thickness and mobility. On the dorsum, it's thin and pliable, allowing for significant movement. On the palmar aspect, it's thick, fibrous, and firmly adherent to the underlying fascia, providing grip and protection. Tumors here can quickly involve deeper structures.

Neurovascular Structures

• Digital Nerves and Arteries: Each digit has two neurovascular bundles, one on each side, running volar to the mid-axial line. These bundles contain the proper digital arteries and nerves, which are incredibly vulnerable during excision, especially near the nail matrix or in the web spaces. Injury here can lead to devastating sensory loss or digital ischemia.
• Radial and Ulnar Arteries: These are the primary blood supply to the hand, forming the superficial and deep palmar arches. Dissections more proximally on the hand or wrist require careful identification and protection.
• Median, Ulnar, and Radial Nerves: These major nerves provide motor and sensory innervation to the hand. Tumors in proximity, especially with perineural invasion, demand wider margins and often necessitate nerve sacrifice or grafting. For example, tumors on the lateral margins of the digits or near the cubital tunnel are high-risk areas for cryosurgery dueing proximity to nerves.

Tendons and Musculature

• Flexor and Extensor Tendons: The intricate network of flexor and extensor tendons allows for the hand's remarkable dexterity. Tumors involving these structures often require partial or complete resection, necessitating complex reconstructive strategies.
• Intrinsic Muscles: The thenar, hypothenar, and interosseous muscles are vital for fine motor control. Their involvement can significantly impact hand function.

Osteology

• Phalanges, Metacarpals, Carpals: The bony architecture of the hand is the scaffolding. For nail matrix lesions, the matrix is intimately adherent to the underlying phalanx. Bone involvement, often seen with invasive lesions, dictates more aggressive resections, including partial phalangectomy or amputation.
• Nail Complex: The nail matrix and nail bed lack the physiologic barriers of the epidermis and dermis found in intact skin. This makes them particularly susceptible to rapid invasion of underlying bone and tendons. The presence of the Hutchinson sign (extension of brown-black pigment from the nail bed, matrix, and nail plate onto the adjacent cuticle and proximal or lateral nail folds) is a strong indicator of subungual melanoma. However, its absence does not rule out the diagnosis.

Preoperative Planning: The Blueprint for Success

Effective preoperative planning is the cornerstone of successful oncologic surgery. We must meticulously stage the patient, visualize the extent of the tumor, and anticipate every step.

Patient Assessment and Staging

1. Patient History and Physical Examination:

   • We've reviewed the patient's history of a changing lesion on the hand, noting its duration and any associated symptoms. We've specifically inquired about risk factors for SCC and melanoma.
   • On physical examination, we precisely characterize the lesion: size, shape, color, presence of irregularity or asymmetry, and any satellite lesions. For subungual lesions, we look for the Hutchinson sign or any new/enlarging pigmented streak wider than 3 mm.
   • Crucially, we perform a thorough regional lymph node examination, palpating the epitrochlear and axillary nodes. This is especially vital for SCCs arising in sites of chronic ulceration, burn scars, or previous radiation therapy, and for any melanoma.

2. Imaging and Diagnostic Studies:

   • Plain Radiographs: Obtained to evaluate for potential bone involvement, particularly for nail matrix lesions.
   • Systemic Workup: For both SCC and melanoma, a chest radiograph, complete blood count (CBC), and liver panel are standard.
   • Advanced Imaging: If there's suspicion of distant metastasis or extensive regional involvement, we proceed with more detailed studies such as CT, MRI, or PET scans to evaluate specific organ systems (CNS, pulmonary, GI, etc.).
   • Histopathologic Confirmation: This is non-negotiable. The diagnosis must be confirmed by adequate histopathologic evaluation. We ensure full-thickness (surface to full depth) perimeter and core samples are obtained. Crucially, suspicious lesions are NEVER shaved, cauterized, or vaporized, as this compromises accurate staging and margin assessment. If there's any uncertainty from the initial pathologist, the slides and imaging are forwarded to an independent expert for review.

Surgical Strategy and Margin Planning

• Oncologic Principle: Always remember: tumor clearance first, reconstruction second. We will not compromise tumor ablation for the sake of an easier reconstruction.
• Margin Determination:
  • Cutaneous SCC: We aim for a 3 to 10 mm margin of disease-free tissue, depending on the diameter and aggressiveness of the tumor.
  • Cutaneous Melanoma:
    • Lesions < 1.5 mm thick on hands/feet: 1 cm margin.
    • Thicker melanomas (> 1.5 mm): 2 cm margin.
  • Nail Matrix SCC:
    • Noninvasive: Mohs technique with grafting.
    • Invasive: Amputation at the distal joint level (DIP for fingers, IP for thumb), if extent allows.
  • Nail Matrix Melanoma: Due to the unique biology and proximity to bone/tendons, Breslow thickness and Clark level are less useful here. For proximal digital melanoma with bone involvement or perineural invasion, complete digital amputation or ray amputation is indicated.
• Sentinel Lymph Node Biopsy (SLNB): For melanomas with intermediate thickness (typically > 1 mm Breslow thickness or with ulceration), or for high-risk SCCs, we will perform SLNB. This involves injecting isosulfan blue dye and/or a radiocolloid around the tumor site, allowing us to identify and excise the draining lymph node(s) for pathologic evaluation. This is typically done either the day before or intraoperatively.
• Reconstructive Ladder: We always have a plan for coverage. This ranges from direct primary closure for small defects to skin grafting (full-thickness or split-thickness) or local/regional flaps (e.g., V-Y advancement, cross-finger, flag, dorsal metacarpal artery, radial forearm flaps) for larger or more complex defects. The choice depends on the defect size, location, and the need to protect vital structures.

Patient Positioning and Anesthesia

• Anesthesia: Today, the patient will be under general anesthesia. For hand cases, a regional block (e.g., axillary block) can provide excellent postoperative analgesia and reduce the need for systemic opioids.
• Positioning: We'll position the patient supine with the affected upper extremity supported on a dedicated hand table. The arm will be abducted and externally rotated for optimal access, particularly if we anticipate an axillary lymph node dissection. We ensure the arm table is stable and provides full support. The hand will be pronated or supinated as needed for optimal exposure of the lesion.
• Tourniquet: A pneumatic tourniquet will be applied to the proximal arm. This provides a bloodless field, which is absolutely critical for precise dissection and accurate margin assessment. We'll inflate it to 250-280 mmHg, or 100 mmHg above systolic blood pressure, ensuring we monitor tourniquet time closely.

Step-by-Step Intraoperative Execution: The Surgeon's View

Alright, everyone, let's scrub in. We've completed our time-out, confirmed the patient, procedure, and site. The field is prepped and draped.

1. Initial Incision and Excision Planning

"Scalpel, please, size 15 blade."

We begin by meticulously marking our planned excision margins with a sterile skin marker. These margins are determined preoperatively based on the tumor type, depth, and location. For this cutaneous melanoma on the dorsum of the hand, we've planned a 2 cm margin, as the Breslow thickness was 2.5 mm.

"Assistant, please ensure good tension on the skin as I make the incision."

• Skin Incision: I make a precise, elliptical incision around the marked margins, extending through the epidermis and dermis into the subcutaneous fat. The goal is to create a fusiform defect that can be closed primarily if the defect is small enough, or will accommodate a graft or flap.
  

  
  
  

This image shows the initial marking and pre-operative appearance of an invasive melanoma.

• Deep Dissection: Using the scalpel and tissue forceps, we carefully dissect through the subcutaneous tissue. We maintain perpendicularity to the skin surface to ensure our margins are truly vertical and not beveled, which can lead to inadequate deep margins.
  

  
  
  

Here, you can see the intraoperative view of an invasive melanoma lesion with margins clearly marked out. Note the blue dye from the isosulfan injection, indicating the lymphatic drainage for sentinel node mapping. This is precisely how we delineate our excision boundaries.

"Let's elevate this full-thickness specimen carefully. We need to go down to the superficial fascia, ensuring we get a clear deep margin."

• Margin Control: For this cutaneous lesion, we're aiming for a margin down to the deep fascia. If the tumor were on a digit, we might need to go down to the paratenon or even periosteum, depending on the depth of invasion.
• Hemostasis: We use electrocautery judiciously for small vessels to maintain a bloodless field, which is paramount for clear visualization of our surgical planes and accurate margin assessment. "Bovie, please, on a low setting."

2. Specimen Orientation and Pathology Submission

"Nurse, please hand me the orientation sutures."

• Specimen Orientation: Once the specimen is excised, we meticulously orient it with sutures (e.g., a long suture at the proximal margin, a short suture at the lateral margin). This is critical for the pathologist to accurately assess the margins and guide any further re-excision if needed.
• Pathology Submission: The specimen is immediately sent to pathology for either frozen section analysis (if Mohs surgery is being performed or if immediate confirmation of clear margins is required) or permanent histopathologic evaluation. For Mohs micrographic surgery, a trained dermatologist is typically present to interpret the frozen sections and guide subsequent excisions layer by layer.

3. Addressing Specific Tumor Locations

Let's consider variations based on tumor location and type as outlined in our preoperative plan.

Nail Matrix Squamous Cell Carcinoma

"For invasive SCC of the nail matrix, as seen in this challenging case..."

This image shows a chronic matrix lesion, initially treated for two years with antibiotics and antifungals, ultimately revealing invasive squamous cell carcinoma on biopsy. This highlights the importance of early and accurate diagnosis.

• Amputation: For invasive lesions, the appropriate technique is amputation at the distal joint level for that digit. For fingers, this means proximal to the distal interphalangeal (DIP) joint. For the thumb, it's proximal to the interphalangeal (IP) joint.
  • Technique: We make a circumferential incision just proximal to the joint line. We identify and ligate the digital neurovascular bundles bilaterally. The flexor and extensor tendons are transected cleanly, allowing for retraction. The bone is then transected with an oscillating saw, ensuring a smooth, non-spiculated cut. The periosteum is carefully managed. The nerve ends are sharply transected high to minimize neuroma formation. The skin flaps are then tailored for a tension-free closure.
• Noninvasive SCC: For noninvasive nail matrix SCC, Mohs technique with grafting is the preferred approach, aiming to preserve as much tissue as possible while achieving clear margins.

Nail Matrix Melanoma

"This patient presented with an invasive matrix melanoma, unfortunately with a delayed presentation, as you can see here."

This image illustrates an invasive matrix melanoma with a delayed presentation, emphasizing the aggressive nature these lesions can exhibit.

• Amputation: Due to the aggressive nature and the lack of biologic barriers in the nail complex, and the proximity to underlying phalanx and tendons, Breslow thickness and Clark level are less useful here. For more proximal digital melanoma with bone involvement or perineural invasion, either complete digital amputation or ray amputation is indicated.
  • Ray Amputation: If metacarpal bone is involved, a ray amputation (removal of the entire digit and its corresponding metacarpal) may be necessary. This is a significant functional deficit but is mandated by oncologic principles. We carefully identify and protect adjacent neurovascular structures and ensure clean bone cuts.

Cutaneous SCC on MP Joint Area

"Observe this invasive SCC on the right second MP joint area in a kidney-pancreas transplant patient, a classic presentation in an immunocompromised individual."

This radial view of invasive squamous cell carcinoma of the right second MP joint area in a kidney-pancreas transplant patient demonstrates a typical presentation of aggressive SCC in an immunocompromised individual.

A dorsal view of the same invasive SCC of the right second MP joint area, further illustrating the extent of the lesion.

"And here, another example, this time on the left thumb MP joint area and web space, highlighting the challenge of these critical anatomical locations."

This dorsal view shows invasive squamous cell carcinoma of the left thumb MP joint area—web space, a functionally critical and anatomically complex region.

An ulnar view of the invasive squamous cell carcinoma of the left thumb MP joint area—web space, providing another perspective on the lesion's extent.

• Wide Local Excision: For these lesions, we perform wide local excision with appropriate margins. Due to their location near joints and tendons, meticulous dissection is required to protect underlying structures. If the tumor involves the joint capsule or bone, we must resect these involved structures to achieve clear margins. This could involve partial capsulotomy or even partial phalangectomy/metacarpal resection.

4. Sentinel Lymph Node Biopsy (SLNB)

"Now, let's proceed with the sentinel lymph node biopsy for our melanoma patient. We injected the isosulfan blue dye and radiocolloid earlier this morning."

• Gamma Probe Use: We use a handheld gamma probe to locate the "hot" node(s) in the axilla, which are the first draining lymph nodes from the tumor site.
• Axillary Incision: Once the hot spot is identified, we make a small incision (typically 3

REFERENCES

1. Abide JM, Nahai F, Bennett RG. The meaning of surgical margins. Plast Reconstr Surg 1984;73:492–497.

2. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial. Ann Surg 1993;218:262–269.

3. Cottel WI. Perineural invasion by squamous-cell carcinoma. J Dermatol Surg Oncol 1982;8:589–600.

4. Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;6:442–449.

5. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–983.

6. Hochwald SN, Coit DG. Role of elective lymph node dissection in melanoma. Semin Surg Oncol 1998;14:276–282.

7. Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma: results of a meta-analysis. Melanoma Res 2000;10:81–92.

8. Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer 2000;83:569–572.

9. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302–313.

10. Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, et al. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 1998;134:983–987.

11. Ollila DW, Hsueh EC, Stern SL, et al. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999;71:209–213.

12. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649–1662.

13. Thomas RM, Amonette RA. Mohs micrographic surgery. Am Fam Physician 1988;37:135–142.

14. Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–766.

15. Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438–441.

16. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318:1159–1162.

17. Wagner JD, Gordon MS, Chuang TY, et al. Current therapy of cutaneous melanoma. Plast Reconstr Surg 2000;105:1774–1801.

18. For melanoma, the follow-up schedule for patients who have surgically resected disease is based on the primary lesion’s Breslow thickness and the nodal involvement. Patients with thin primary melanoma and negative nodes are followed with clinical examination for evidence of occurrence every 6 months for the first 2 to 3 years and then yearly for 2 to 3 years beyond that. Patients with intermediate or thick melanomas and negative regional nodes are followed every 3 to 6 months for the first 2 to 3 years and every 6 to 12 months for the next 2 to 3 years. Patients with resected regional disease require follow-up every 3 to 4 months for the first 2 years, then every 6 months up to year 5, and yearly beyond that. All patients must maintain routine lifelong dermatologic screening. Patients with one melanoma remain at higher-than-average risk for a second primary melanoma and are at risk for basal cell and squamous cell carcinomas.

OUTCOMES
- Squamous cell carcinoma is the second most common type of skin malignancy. Although the basal cell and squamous types of skin cancer are the most common of all malignancies, they account for less than 0.1% of cancer deaths.

• The overall cure rate for squamous cell carcinoma is directly related to the stage of the disease and the type of treatment used. Since squamous cell carcinoma is not a reportable disease, precise 5-year cure rates are not known.

• Melanoma 5-year survival rates are related to stage and range from 18% for stage IV to 99% for stage IA.

COMPLICATIONS
- Sentinel lymph node biopsy is not without complications. The most common complications are hematoma and seroma. The rate of lymphedema after sentinel lymph node biopsy has